Cercador
Ets a: Portada > Recerca > Ajuts a la recerca

Ajuts a la recerca

IMI -Discovery and validation of novel endpoints in dry age-related macular degeneration and diabetic retinopathy

Organisme

EU- Innovative Medicines Initiative

Objecte

Specific challenge

Diseases of the retina are among the leading causes of blindness worldwide. Substantial progress has been made in the treatment of neovascular age-related macular degeneration (neovascular AMD) and diabetic macular edema (DME). However, for other common retinal conditions such as the dry form of AMD (dry AMD) or diabetic retinopathy (DR) treatment options remain limited. One major development hurdle is the lack of suitable, patient-relevant study endpoints with clinical relevance for both early exploratory and pivotal trials. Moreover, there are gaps in the understanding on how preclinical findings translate into outcomes.
 

Termini oficial

Deadline for submission: 12 November 2014 – 17:00 CET

Termini IISPV

Declaration of interest: IISPV's deadline: August 31, 2014 (europa@iispv.cat) Full proposal: IISPV's deadline: October 29, 2014

Enllaços relacionats

Pujar

Fes-ho córrer

  • Facebook
  • del.icio.us
  • TwitThis
  • Meneame
  • GoogleReader
  • eMail

IISPV

IISPVInstitut d'Investigació Sanitària Pere Virgili (IISPV)

Work Centre d'R+D+I en Nutrició i Salut
Avda. de la Universitat, 1 - 2a planta
E-43204 Reus (Tarragona)

Tel. Work977 75 93 94 http://www.iispv.cathttp://www.iispv.cat

Generalitat de Catalunya

Universitat Rovira i Virgili (URV)

ICS - Institut Català de la Salut

Grup Sagessa

Centre de Recerca de Catalunya

Institut Pere Mata, Hospital Psiquiàtric Universitari

Universitat Excel·lència - Universitat Rovira i Virgili - Investigació excel·lència - Postgrau Excel·lència

Twitter

Linkedin

Youtube

© IISPV, tots els drets reservats